Counsel To Get Up To $93M In Fees In Xarelto MDL

By Mike Curley · March 24, 2020, 10:13 PM EDT

A Louisiana federal judge has awarded counsel representing plaintiffs in multidistrict litigation alleging Bayer and Janssen Pharmaceuticals failed to warn about internal bleeding risks of the blood thinner Xarelto up to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

In Re: Xarelto (Rivaroxaban) Products Liability Litigation

Case Number

Court

Louisiana Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

December 12, 2014

Recent Articles By Mike

August 20, 2024
Fed Circ. Finds No Fault In Denial Of Flu Vaccine Claim
August 15, 2024
Pharmacy Can't Dodge Novo Nordisk's Diabetes Drug Suit
August 14, 2024
Florida AG Can't Nix Hospitals', School Boards' Opioid Claims
August 02, 2024
6th Circ. Upholds Federal Hospital's Win In Infant Death Suit
August 02, 2024
Four Plaintiffs Tossed From Merck Gardasil Vaccine MDL
July 26, 2024
Judge Allows Emotional Damages In Deaf Patient's Bias Suit
July 16, 2024
3rd Circ. Backs Tossing Over 1K Suits In Merck Vaccine MDL
June 28, 2024
Philips Gets OK For $25M Med Monitoring Deal In CPAP MDL
June 27, 2024
Whole Foods, Hain Want Full 5th Circ. Review Of Baby Food Suit
June 20, 2024
11th Circ. Upholds $2.5M Pelvic Mesh Verdict, Rules Suit Timely